OncologyPRACTICENCT06668818
Clinical Nursing Practice Supported by Results of Research: Mixed-method Study
An observational study of Oncology, run by Centro di Riferimento Oncologico - Aviano at 1 site in Italy.
Trial summary
The purpose of the study is to assess the attitudes and the use of research by nurses at the IRCCS-CRO Aviano. Furthermore, it will make it possible to identify attitudes towards the use/non-use of research results, specific training needs and targeted interventions to ensure adequate care for cancer patients along… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Oncology
- How many people
- 205 participants
- Where
- 1 siteItaly
- Study dates
- 7 Mar 2024to 7 Mar 2025
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Nurses employed at IRCCS-CRO Aviano and patients admitted to the institution as in-patients
Who may be able to join
- All nurses employed at IRCCS-CRO Aviano under fixed-term and permanent contract on 15 September 2023;
- Nursing activities in the departments of medical and surgical oncology and high technologies;
- Full-time and part-time employment contract;
- Signature of consent for participation in the study and processing of personal data (Privacy).
- Patient inclusion criteria:
- Patients admitted to the institution as in-patients;
Show all 9Show fewer
- Age ≥ 18 years;
- Signature of consent for participation in the study and processing of personal data (Privacy);
- Good understanding of the Italian language.
Who cannot join
- Lack of willingness/interest in participating in the study and signing the consent.
- Patient exclusion criteria:
- Day-Hospital patients;
- Age < 18 years;
- Diagnosis of cognitive dysfunction or psychiatric disorders;
- Difficulties in understanding the Italian language.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
Aviano, Pordenone, 33081
Lucia Cadorin, PhD, 0434 659508, lcadorin@cro.it
Lucia Cadorin, PhD
About this study
The purpose of the study is to assess the attitudes and the use of research by nurses at the IRCCS-CRO Aviano. Furthermore, it will make it possible to identify attitudes towards the use/non-use of research results, specific training needs and targeted interventions to ensure adequate care for cancer patients along the disease course, derived from a constant updating of nursing skills. The study will involve nurses working in different care settings of the Institute and some patients who will be able to express their care needs and research priorities, making a direct contribution towards development of care centred on the health needs, preferences and values of the cancer patients.
- Conditions
- Oncology
- Medical subject headings
- Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Nurses employed at IRCCS-CRO Aviano | Not described | |
| Patients admitted to the IRCCS-CRO Aviano as in-patients | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
To assess the attitudes and use of research by nurses IRCCS of Aviano
The Modified Research Utilization Questionnaire (M-RUQ), consisting of 22 items across three subscales assessed on a 5-point Likert scale (range: 22-110), will be used for data collection. Total scores are computed by summing and averaging domain scores, with reverse-scoring for negative items. Missing data will be imputed with item means, and results presented as mean ± standard deviation.
Measured: 1 year
Secondary outcomes (2)
To identify nursing issues, research priorities, and educational needs of nurses at IRCCS Aviano.
he qualitative data obtained from the research (using interview and focus group method) will be evaluated with inductive content analysis, following Colaizzi's framework (1978). In order to enhance the validity of the data, two researchers will independently examine the transcripts, and comprehensive readings will be conducted. Codes will be generated and compared by interpreting differences and similarities, from which themes and sub-themes will be obtained
Measured: 1 year
To explore care needs and research priorities of patients at IRCCS Aviano
he qualitative data obtained from the research (using interview and focus group method) will be evaluated with inductive content analysis, following Colaizzi's framework (1978). In order to enhance the validity of the data, two researchers will independently examine the transcripts, and comprehensive readings will be conducted. Codes will be generated and compared by interpreting differences and similarities, from which themes and sub-themes will be obtained
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Oct 2024
- Study start7 Mar 2024
- Primary completion7 Mar 2025 (estimated)
- Study completion7 Mar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OncologyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 205 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centro di Riferimento Oncologico - Aviano
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Lucia Cadorin, PhD, Principal investigator, Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06668818
- Sponsor's protocol ID
- CRO-2023-83
- Acronym
- PRACTICE
- Status last verified
- Nov 2024
- First submitted
- 30 Oct 2024
- Last updated
- 3 Dec 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Nursing Practice Supported by Results of Research: Mixed-method Study
- ClinicalTrials.gov ID
- NCT06668818
- Acronym / sponsor ID
- PRACTICE / CRO-2023-83
- Conditions
- Oncology
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 205 participants (estimated)
- Lead sponsor
- Centro di Riferimento Oncologico - AvianoUniversity, hospital or other
- Study start
- 7 Mar 2024 (actual)
- Primary completion
- 7 Mar 2025 (estimated)
- Study completion
- 7 Mar 2025 (estimated)
- First posted
- 31 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to assess the attitudes and the use of research by nurses at the IRCCS-CRO Aviano. Furthermore, it will make it possible to identify attitudes towards the use/non-use of research results, specific training needs and targeted interventions to ensure adequate care for cancer patients along the disease course, derived from a constant updating of nursing skills. The study will involve nurses working in different care settings of the Institute and some patients who will be able to express their care needs and research priorities, making a direct contribution towards development of care centred on the health needs, preferences and values of the cancer patients.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Nurses employed at IRCCS-CRO Aviano | – | – |
| Patients admitted to the IRCCS-CRO Aviano as in-patients | – | – |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Nurses employed at IRCCS-CRO Aviano and patients admitted to the institution as in-patients
Key inclusion criteria (9 listed)
- All nurses employed at IRCCS-CRO Aviano under fixed-term and permanent contract on 15 September 2023;
- Nursing activities in the departments of medical and surgical oncology and high technologies;
- Full-time and part-time employment contract;
- Signature of consent for participation in the study and processing of personal data (Privacy).
- Patients admitted to the institution as in-patients;
Key exclusion criteria (6 listed)
- Lack of willingness/interest in participating in the study and signing the consent.
- Day-Hospital patients;
- Age < 18 years;
- Diagnosis of cognitive dysfunction or psychiatric disorders;
- Difficulties in understanding the Italian language.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
To assess the attitudes and use of research by nurses IRCCS of Aviano
Time frame: 1 year
The Modified Research Utilization Questionnaire (M-RUQ), consisting of 22 items across three subscales assessed on a 5-point Likert scale (range: 22-110), will be used for data collection. Total scores are computed by summing and averaging domain scores, with reverse-scoring for negative items. Missing data will be imputed with item means, and results presented as mean ± standard deviation.
2 secondary outcomes
To identify nursing issues, research priorities, and educational needs of nurses at IRCCS Aviano.
Time frame: 1 year
To explore care needs and research priorities of patients at IRCCS Aviano
Time frame: 1 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Dec 2024.
Related trials for Oncology
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Lucia Cadorin, PhD principal investigator
Centro di Riferimento Oncologico (CRO) di Aviano - IRCCS
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Oncology, run by Centro di Riferimento Oncologico - Aviano at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Lucia Cadorin, PhD (0434 659508, lcadorin@cro.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To assess the attitudes and use of research by nurses IRCCS of Aviano (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2024.